Osixim 200 LB Tablet is a combination antibiotic formulation containing Cefixime 200 mg and Lactobacillus 60 million spores, designed to treat a variety of bacterial infections while supporting gastrointestinal health. Cefixime, a third-generation cephalosporin antibiotic, exhibits broad-spectrum activity against Gram-positive and Gram-negative bacteria by inhibiting bacterial cell wall synthesis, thereby effectively managing infections such as urinary tract infections, respiratory tract infections, otitis media, and uncomplicated gonorrhea. The inclusion of Lactobacillus spores serves as a probiotic adjunct to restore and maintain the natural balance of gut flora, which may be disrupted during antibiotic therapy, reducing the risk of antibiotic-associated diarrhea and other gastrointestinal disturbances. Osixim 200 LB is indicated for patients requiring effective antibacterial treatment with concurrent probiotic support to enhance tolerability and reduce adverse effects related to dysbiosis. It is administered orally, with dosage and duration tailored according to the severity and type of infection, as well as patient-specific factors. Caution is advised in patients with known hypersensitivity to cephalosporins or probiotics. As with all antibiotics, adherence to prescribed therapy is critical to prevent resistance development. Consultation with a healthcare professional is recommended before initiating treatment with Osixim 200 LB Tablet.